Ginkgolides and neuroprotective effects

Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes

Volumn , Issue , 2013, Pages 3697-3741

  Omar, Syed Haris ^a  

^a CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Ginkgo; Ginkgolides; Neuroprotection; PAF antagonism; Terpenoids

Indexed keywords

EID: 85015094823     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-22144-6_146     Document Type: Chapter

References (243)

1. Hori T (1997) Ginkgo biloba: a global treasure: from biology to medicine. Springer, Tokyo
2. Zhou Z (1991) Phylogeny and evolutionary trends of Mesozoic ginkgoaleans-a preliminary assessment. Rev Palaeobot Palynol 68(3-4):203-216. doi:10.1016/0034-6667(91)90024-w
3. Melzheimer V, Lichius JJ (2000) Ginkgo biloba L.: Aspects of the systematical and applied botany. In: van Beek TA (ed) Ginkgo biloba. Harwood, Amsterdam, p 25
4. Li H-L (1956) A horticultural and botanical history of Ginkgo. Morris Arbor Bull 7:3-12
5. Drieu K, Jaggy H (2000) History, development and constituents of EGb 761. In: van Beek TA (ed) Ginkgo biloba. Harwood, Amsterdam, p 267
6. Anonymous (1999) Pharmacopeial Forum, vol 25: 7754
7. Srinivasan VS (2000) Medicinal and aromatic plants: industrial profiles, vol 12. Harwood, Amsterdam
8. Blumenthal M (1998) The complete German Commission E monographs: therapeutic guide to herbal medicines. Thieme, Boston
9. World Health Organization (1999) WHO monographs on selected medicinal plants, vol 1. World Health Organization, Geneva, pp 154-167
10. Keiji W (2000) Food poisoning by Ginkgo seeds. The role of 4-O-methylpyridoxine. In: van Beek TA (ed) Ginkgo biloba. Harwood, Amsterdam, p 453
11. Lichtblau D, Berger JM, Nakanishi K (2002) Efficient extraction of ginkgolides and bilobalide from Ginkgo biloba leaves. J Nat Prod 65(10):1501-1504
12. Furukawa S (1932) Studies on the constituents of the “Ginkgo biloba” L., leaves. Part I and II. Sci Pap Inst Phys Chem Res 19:27-42
13. Maruyama M, Terahara A, Itagaki Y, Nakanishi K (1967) The ginkgolides. I. Isolation and characterization of the various groups. Tetrahedron Lett 8(4):299-302. doi:10.1016/s0040-4039(00)71538-3
14. Maruyama M, Terahara A, Itagaki Y, Nakanishi K (1967) The ginkgolides. II. Derivation of partial structures. Tetrahedron Lett 8(4):303-308. doi:10.1016/s0040-4039(00)71539-5
15. Maruyama M, Terahara A, Nakadaira Y, Woods MC, Nakanishi K (1967) The ginkgolides. III. The structure of the ginkgolides. Tetrahedron Lett 8(4):309-313. doi:10.1016/s0040-4039(00)71540-1
16. Maruyama M, Terahara A, Nakadaira Y, Woods MC, Takagi Y, Nakanishi K (1967) The ginkgolides. IV. Stereochemistry of the ginkgolides. Tetrahedron Lett 8(4):315-319. doi:10.1016/s0040-4039(00)71541-3
17. Woods MC, Miura I, Nakadaira Y, Terahara A, Maruyama M, Nakanishi K (1967) The ginkgolides. V. Some aspects of their NMR spectra. Tetrahedron Lett 8(4):321-326. doi:10.1016/s0040-4039(00)71542-5
18. Nakanishi K (1967) The ginkgolides. Pure Appl Chem 14(1):89-113
19. Okabe K, Yamada K, Yamamura S, Takad S (1967) Ginkgolides. J Chem Soc C 21:2201-2206. doi:10.1039/J39670002201
20. Sakabe N, Takada S, Okabe K (1967) The structure of ginkgolide A, a novel diterpenoid trilactone. Chem Commun (Lond) 6:259-261. doi:10.1039/C19670000259
21. Weinges K, Hepp M, Jaggy H (1987) Chemie der Ginkgolide, II. Isolierung und Strukturaufklarung eines neuen Ginkgolids. Liebigs Ann Chem 6:521-526
22. Wang Y, Sheng LS, Lou FC (2001) Analysis and structure identification of trace constituent in the total ginkgolide by using LC/DAD/ESI/MS. Yao Xue Xue Bao 36(8):606-608
23. van Beek TA (2005) Ginkgolides and bilobalide: their physical, chromatographic and spectroscopic properties. Bioorg Med Chem 13(17):5001-5012. doi:10.1016/j.bmc.2005.05.056
24. Chu X, Ci X, He J, Wei M, Yang X, Cao Q, Li H, Guan S, Deng Y, Pang D, Deng X (2011) A novel anti-inflammatory role for ginkgolide B in asthma via inhibition of the ERK/MAPK signaling pathway. Molecules 16(9):7634-7648. doi:10.3390/molecules16097634
25. Koch E (2005) Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. Phytomedicine 12(1-2):10-16
26. Tosaki A, Droy-Lefaix MT, Pali T, Das DK (1993) Effects of SOD, catalase, and a novel antiarrhythmic drug, EGB 761, on reperfusion-induced arrhythmias in isolated rat hearts. Free Radic Biol Med 14(4):361-370
27. Pretner E, Amri H, Li W, Brown R, Lin CS, Makariou E, Defeudis FV, Drieu K, Papadopoulos V (2006) Cancer-related overexpression of the peripheral-type benzodiazepine receptor and cytostatic anticancer effects of Ginkgo biloba extract (EGb 761). Anticancer Res 26(iss 1A):9-22
28. Chao JC, Chu CC (2004) Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells. World J Gastroenterol 10(1):37-41
29. Kudolo GB (2001) The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus. J Clin Pharmacol 41(6):600-611
30. Kudolo GB, Wang W, Elrod R, Barrientos J, Haase A, Blodgett J (2006) Short-term ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, prediabetic or type 2 diabetic subjects-a randomized double-blind placebo-controlled crossover study. Clin Nutr 25(1):123-134. doi:10.1016/j.clnu.2005.10.001
31. Beck JC, Goodner CJ, Wilson C, Wilson D, Glidden D, Baskin DG, Lernmark A, Braquet P (1991) Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat. Autoimmunity 9(3):225-235
32. Yenilmez A, Kilic FS, Sirmagul B, Isikli B, Aral E, Oner S (2007) Preventive effects of Ginkgo biloba extract on ischemia-reperfusion injury in rat bladder. Urol Int 78(2):167-172. doi:10.1159/000098077
33. Keles M, Demirci N, Yildirim A, Atamanalp S, Altinkaynak K (2008) Protective effects of N-acetylcysteine and Ginkgo biloba extract on ischaemia-reperfusion-induced hepatic DNA damage in rats. Clin Exp Med 8(4):193-198. doi:10.1007/s10238-008-0005-1
34. Lim S, Yoon JW, Kang SM, Choi SH, Cho BJ, Kim M, Park HS, Cho HJ, Shin H, Kim YB, Kim HS, Jang HC, Park KS (2011) EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One 6(6):e20301. doi:10.1371/journal.pone.0020301
35. Boonkaew T, Camper ND (2005) Biological activities of Ginkgo extracts. Phytomedicine 12(4):318-323
36. Sati SC, Joshi S (2011) Antibacterial activities of Ginkgo biloba L. leaf extracts. Scientific World Journal 11:2241-2246. doi:10.1100/2011/545421
37. Wei Z, Peng Q, Lau BH, Shah V (1999) Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells. Gen Pharmacol 33(5):369-375
38. Woo CW, Cheung F, Chan VW, Siow YL, Karmin O (2003) Homocysteine stimulates inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide. Mol Cell Biochem 243(1-2):37-47
39. Pietri S, Maurelli E, Drieu K, Culcasi M (1997) Cardioprotective and anti-oxidant effects of the terpenoid constituents of Ginkgo biloba extract (EGb 761). J Mol Cell Cardiol 29(2):733-742. doi:10.1006/jmcc.1996.0316
40. Kim YS, Pyo MK, Park KM, Park PH, Hahn BS, Wu SJ, Yun-Choi HS (1998) Antiplatelet and antithrombotic effects of a combination of ticlopidine and ginkgo biloba ext (EGb 761). Thromb Res 91(1):33-38
41. Ryu KH, Han HY, Lee SY, Jeon SD, Im G-J, Lee BY, Kim K, Lim K-M, Chung J-H (2009) Ginkgo biloba extract enhances antiplatelet and antithrombotic effects of cilostazol without prolongation of bleeding time. Thromb Res 124(3):328-334. doi: 10.1016/j.thromres.2009.02.010
42. Wang Q, Zhao WZ, Ma CG (2000) Protective effects of Ginkgo biloba extract on gastric mucosa. Acta Pharmacol Sin 21(12):1153-1156
43. Chen SH, Liang YC, Chao JC, Tsai LH, Chang CC, Wang CC, Pan S (2005) Protective effects of Ginkgo biloba extract on the ethanol-induced gastric ulcer in rats. World J Gastroenterol 11(24):3746-3750
44. Wu Y, Li S, Cui W, Zu X, Du J, Wang F (2008) Ginkgo biloba extract improves coronary blood flow in healthy elderly adults: role of endothelium-dependent vasodilation. Phytomedicine 15(3):164-169. doi: 10.1016/j.phymed.2007.12.002
45. Ehrenreich H, Siren AL (2001) Neuroprotection-what does it mean?-what means do we have? Eur Arch Psychiatry Clin Neurosci 251(4):149-151
46. Le Poncin LM, Rapin J, Rapin JR (1980) Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats. Arch Int Pharmacodyn Ther 243(2):236-244
47. Karcher L, Zagermann P, Krieglstein J (1984) Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia. Naunyn Schmiedebergs Arch Pharmacol 327(1):31-35
48. Krieglstein J, Beck T, Seibert A (1986) Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. Life Sci 39(24):2327-2334
49. Janssens D, Michiels C, Delaive E, Eliaers F, Drieu K, Remacle J (1995) Protection of hypoxia-induced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobalide. Biochem Pharmacol 50(7):991-999
50. Duverger D, DeFeudis FV, Drieu K (1995) Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) on cerebral glucose utilization in the rat: an autoradiographic study. Gen Pharmacol 26(6):1375-1383
51. Shen M, Lu Z, Ye Q (2000) Effects of an extract of Ginkgo biloba on the blood flow of brains and back legs of dogs. Zhong Yao Cai 23(12):764-766
52. Sun BL, Yuan H, Yang MF, Xia ZL, Zhang SM, Wang LX (2007) Effects of extract of Ginkgo biloba on intracranial pressure, cerebral perfusion pressure, and cerebral blood flow in a rat model of subarachnoid haemorrhage. Int J Neurosci 117(5):655-665. doi:10.1080/00207450600773871
53. Grassel E (1992) Effect of Ginkgo biloba extract on mental performance. Double-blind study using computerized measurement conditions in patients with cerebral insufficiency. Fortschr Med 110(5):73-76
54. Hopfenmuller W (1994) Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age. Arzneimittelforschung 44(9):1005-1013
55. Mashayekh A, Pham DL, Yousem DM, Dizon M, Barker PB, Lin DD (2011) Effects of Ginkgo biloba on cerebral blood flow assessed by quantitative MR perfusion imaging: a pilot study. Neuroradiology 53(3):185-191. doi:10.1007/s00234-010-0790-6
56. Winter E (1991) Effects of an extract of Ginkgo biloba on learning and memory in mice. Pharmacol Biochem Behav 38(1):109-114
57. Stoll S, Scheuer K, Pohl O, Muller WE (1996) Ginkgo biloba extract (EGb 761) independently improves changes in passive avoidance learning and brain membrane fluidity in the aging mouse. Pharmacopsychiatry 29(4):144-149. doi: 10.1055/s-2007-979561
58. Cohen-Salmon C, Venault P, Martin B, Raffalli-Sebille MJ, Barkats M, Clostre F, Pardon MC, Christen Y, Chapouthier G (1997) Effects of Ginkgo biloba extract (EGb 761) on learning and possible actions on aging. J Physiol Paris 91(6):291-300
59. Winter JC (1998) The effects of an extract of Ginkgo biloba, EGb 761, on cognitive behavior and longevity in the rat. Physiol Behav 63(3):425-433
60. Wirth S, Stemmelin J, Will B, Christen Y, Di Scala G (2000) Facilitative effects of EGb 761 on olfactory recognition in young and aged rats. Pharmacol Biochem Behav 65(2):321-326
61. Rickard NS, Kowadlo N, Gibbs ME (2001) Effect of the Ginkgo biloba extract, EGb 761, on memory formation in day-old chicks. Pharmacol Biochem Behav 69(3-4): 351-358
62. Blecharz-Klin K, Piechal A, Joniec I, Pyrzanowska J, Widy-Tyszkiewicz E (2009) Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats. Acta Neurobiol Exp (Wars) 69(2):217-231
63. Walesiuk A, Braszko JJ (2010) Gingkoselect alleviates chronic corticosterone-induced spatial memory deficits in rats. Fitoterapia 81(1):25-29. doi:10.1016/j.fitote.2009.06.020
64. Abdel-Wahab BA, Abd El-Aziz SM (2012) Ginkgo biloba protects against intermittent hypoxia-induced memory deficits and hippocampal DNA damage in rats. Phytomedicine 19(5):444-450. doi:10.1016/j.phymed.2011.11.011
65. Hindmarch I (1986) Activity of Ginkgo biloba extract on short-term memory. Presse Med 15(31):1592-1594
66. Brautigam MRH, Blommaert FA, Verleye G, Castermans J, Jansen Steur ENH, Kleijnen J (1998) Treatment of age-related memory complaints with Ginkgo biloba extract: a randomized double blind placebo-controlled study. Phytomedicine 5(6):425-434. doi:10.1016/s0944-7113(98)80038-x
67. Moulton PL, Boyko LN, Fitzpatrick JL, Petros TV (2001) The effect of Ginkgo biloba on memory in healthy male volunteers. Physiol Behav 73(4):659-665
68. van Dongen M, van Rossum E, Kessels A, Sielhorst H, Knipschild P (2003) Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J Clin Epidemiol 56(4):367-376
69. Mix JA, Crews WD Jr (2000) An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. J Altern Complement Med 6(3):219-229
70. Kennedy DO, Scholey AB, Wesnes KA (2000) The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers. Psychopharmacology (Berl) 151(4):416-423
71. Hartley DE, Heinze L, Elsabagh S, File SE (2003) Effects on cognition and mood in postmenopausal women of 1-week treatment with Ginkgo biloba. Pharmacol Biochem Behav 75(3):711-720
72. Elsabagh S, Hartley DE, Ali O, Williamson EM, File SE (2005) Differential cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy young volunteers. Psychopharmacology (Berl) 179(2):437-446. doi:10.1007/s00213-005-2206-6
73. Dartigues JF, Carcaillon L, Helmer C, Lechevallier N, Lafuma A, Khoshnood B (2007) Vasodilators and nootropics as predictors of dementia and mortality in the PAQUID cohort. J Am Geriatr Soc 55(3):395-399. doi:10.1111/j.1532-5415.2007.01084.x
74. Kennedy DO, Haskell CF, Mauri PL, Scholey AB (2007) Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine. Hum Psychopharmacol 22(4):199-210. doi:10.1002/hup.837
75. Lovera J, Bagert B, Smoot K, Morris CD, Frank R, Bogardus K, Wild K, Oken B, Whitham R, Bourdette D (2007) Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Mult Scler 13(3):376-385. doi:10.1177/1352458506071213
76. Wang BS, Wang H, Song YY, Qi H, Rong ZX, Zhang L, Chen HZ (2010) Effectiveness of standardized ginkgo biloba extract on cognitive symptoms of dementia with a six-month treatment: a bivariate random effect meta-analysis. Pharmacopsychiatry 43(3):86-91. doi:10.1055/s-0029-1242817
77. Kaschel R (2011) Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers. Phytomedicine 18(14):1202-1207. doi:10.1016/j.phymed.2011.06.021
78. Brunello N, Racagni G, Clostre F, Drieu K, Braquet P (1985) Effects of an extract of Ginkgo biloba on noradrenergic systems of rat cerebral cortex. Pharmacol Res Commun 17(11):1063-1072
79. Huguet F, Tarrade T (1992) Alpha 2-adrenoceptor changes during cerebral ageing. The effect of Ginkgo biloba extract. J Pharm Pharmacol 44(1):24-27
80. Hadjiivanova CI, Petkov VV (2002) Effect of Ginkgo biloba extract on beta-adrenergic receptors in different rat brain regions. Phytother Res 16(5):488-490. doi:10.1002/ptr.933
81. Fehske CJ, Leuner K, Muller WE (2009) Ginkgo biloba extract (EGb761®) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol Res 60(1):68-73. doi:10.1016/j.phrs.2009.02.012
82. Ellis KA, Nathan PJ (2001) The pharmacology of human working memory. Int J Neuropsychopharmacol 4(3):299-313. doi:10.1017/S1461145701002541
83. Furey ML, Pietrini P, Haxby JV (2000) Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 290(5500):2315-2319. doi:10.1126/science.290.5500.2315
84. Rusted JM (1988) Dissociative effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology (Berl) 96(4):487-492
85. Kristofikova Z, Klaschka J (1997) In vitro effect of Ginkgo biloba extract (EGb 761) on the activity of presynaptic cholinergic nerve terminals in rat hippocampus. Dement Geriatr Cogn Disord 8(1):43-48
86. Chopin P, Briley M (1992) Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology (Berl) 106(1):26-30
87. Taylor JE (1986) Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract. Presse Med 15(31):1491-1493
88. Wu WR, Zhu XZ (1999) Involvement of monoamine oxidase inhibition in neuroprotective and neurorestorative effects of Ginkgo biloba extract against MPTP-induced nigrostriatal dopaminergic toxicity in C57 mice. Life Sci 65(2):157-164
89. Ahmad M, Saleem S, Ahmad AS, Yousuf S, Ansari MA, Khan MB, Ishrat T, Chaturvedi RK, Agrawal AK, Islam F (2005) Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences. J Neurochem 93(1):94-104. doi:10.1111/j.1471-4159.2005.03000.x
90. Rojas P, Serrano-Garcia N, Mares-Samano JJ, Medina-Campos ON, Pedraza-Chaverri J, Ogren SO (2008) EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Eur J Neurosci 28(1):41-50. doi:10.1111/j.1460-9568.2008.06314.x
91. Yoshitake T, Yoshitake S, Kehr J (2010) The Ginkgo biloba extract EGb 761(R) and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex. Br J Pharmacol 159(3):659-668. doi:10.1111/j.1476-5381.2009.00580.x
92. Yeh KY, Wu CH, Tai MY, Tsai YF (2011) Ginkgo biloba extract enhances noncontact erection in rats: the role of dopamine in the paraventricular nucleus and the mesolimbic system. Neuroscience 189:199-206. doi:10.1016/j.neuroscience.2011.05.025
93. Prehn JH, Krieglstein J (1993) Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo. J Neurosci Res 34(2):179-188. doi:10.1002/jnr.490340205
94. Nogami K, Hirashima Y, Endo S, Takaku A (1997) Involvement of platelet-activating factor (PAF) in glutamate neurotoxicity in rat neuronal cultures. Brain Res 754(1-2):72-78
95. Zhu L, Wu J, Liao H, Gao J, Zhao XN, Zhang ZX (1997) Antagonistic effects of extract from leaves of Ginkgo biloba on glutamate neurotoxicity. Zhongguo Yao Li Xue Bao 18(4):344-347
96. Wang S-J, Chen H-H (2005) Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals. Eur J Pharmacol 514(2-3):141-149. doi:10.1016/j.ejphar.2005.03.027
97. Zhao Z, Liu N, Huang J, Lu PH, Xu XM (2011) Inhibition of cPLA2 activation by Ginkgo biloba extract protects spinal cord neurons from glutamate excitotoxicity and oxidative stress-induced cell death. J Neurochem 116(6):1057-1065. doi:10.1111/j.1471-4159.2010.07160.x
98. Grasel I, Reuter G (1998) Analysis of 6-hydroxykynurenic acid in Ginkgo biloba and Ginkgo preparations. Planta Med 64(6):566-570
99. Ivic L, Sands TT, Fishkin N, Nakanishi K, Kriegstein AR, Stromgaard K (2003) Terpene trilactones from Ginkgo biloba are antagonists of cortical glycine and GABA(A) receptors. J Biol Chem 278(49):49279-49285. doi:10.1074/jbc.M304034200
100. Huang SH, Duke RK, Chebib M, Sasaki K, Wada K, Johnston GA (2004) Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors. Eur J Pharmacol 494(2-3):131-138. doi:10.1016/j.ejphar.2004.04.051
101. Amri H, Ogwuegbu SO, Boujrad N, Drieu K, Papadopoulos V (1996) In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides. Endocrinology 137(12):5707-5718
102. Ramassamy C, Christen Y, Clostre F, Costentin J (1992) The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5-hydroxytryptamine: in-vitro and ex-vivo studies. J Pharm Pharmacol 44(11):943-945
103. Huguet F, Drieu K, Piriou A (1994) Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761). J Pharm Pharmacol 46(4):316-318
104. Shah ZA, Sharma P, Vohora SB (2003) Ginkgo biloba normalises stress-elevated alterations in brain catecholamines, serotonin and plasma corticosterone levels. Eur Neuropsycho-pharmacol 13(5):321-325
105. Bolanos-Jimenez F, Manhaes de Castro R, Sarhan H, Prudhomme N, Drieu K, Fillion G (1995) Stress-induced 5-HT1A receptor desensitization: protective effects of Ginkgo biloba extract (EGb 761). Fundam Clin Pharmacol 9(2):169-174
106. Shih JC, Chen K, Ridd MJ, Seif I (2000) Ginkgo biloba abolishes aggression in mice lacking MAO A. Antioxid Redox Signal 2(3):467-471. doi:10.1089/15230860050192242
107. Winter JC, Timineri D (1999) The discriminative stimulus properties of EGb 761, an extract of Ginkgo biloba. Pharmacol Biochem Behav 62(3):543-547
108. Pincemail J, Thirion A, Dupuis M, Braquet P, Drieu K, Deby C (1987) Ginkgo biloba extract inhibits oxygen species production generated by phorbol myristate acetate stimulated human leukocytes. Experientia 43(2):181-184
109. Maitra I, Marcocci L, Droy-Lefaix MT, Packer L (1995) Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol 49(11):1649-1655
110. Kobuchi H, Packer L (1997) Bio-normalizer modulates interferon-gamma-induced nitric oxide production in the mouse macrophage cell line RAW 264.7. Biochem Mol Biol Int 43(1):141-152
111. Marcocci L, Maguire JJ, Droy-Lefaix MT, Packer L (1994) The nitric oxide-scavenging properties of Ginkgo biloba extract EGb 761. Biochem Biophys Res Commun 201(2):748-755
112. Schipper HM (2000) Heme oxygenase-1: role in brain aging and neurodegeneration. Exp Gerontol 35(6-7):821-830
113. Zhuang H, Pin S, Christen Y, Dore S (2002) Induction of heme oxygenase 1 by Ginkgo biloba in neuronal cultures and potential implications in ischemia. Cell Mol Biol (Noisy-le-Grand) 48(6):647-653
114. Bastianetto S, Quirion R (2002) EGb 761 is a neuroprotective agent against beta-amyloid toxicity. Cell Mol Biol (Noisy-le-Grand) 48(6):693-697
115. Nada SE, Shah ZA (2012) Preconditioning with Ginkgo biloba (EGb 761(R)) provides neuroprotection through HO1 and CRMP2. Neurobiol Dis 46(1):180-189. doi:10.1016/j.nbd.2012.01.006
116. Bridi R, Crossetti FP, Steffen VM, Henriques AT (2001) The antioxidant activity of standardized extract of Ginkgo biloba (EGb 761) in rats. Phytother Res 15(5):449-451
117. Colak O, Sahin A, Alatas O, Inal M, Yasar B, Kiper H (1998) The effect of Ginkgo biloba on the activity of catalase and lipid peroxidation in experimental strangulation ileus. Int J Clin Lab Res 28(1):69-71
118. Sasaki K, Hatta S, Wada K, Ueda N, Yoshimura T, Endo T, Sakata M, Tanaka T, Haga M (2002) Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Life Sci 70(14):1657-1667
119. Rimbach G, Gohil K, Matsugo S, Moini H, Saliou C, Virgili F, Weber SU, Packer L (2001) Induction of glutathione synthesis in human keratinocytes by Ginkgo biloba extract (EGb761). Biofactors 15(1):39-52
120. Zhao HW, Li XY (2002) Ginkgolide A, B, and huperzine A inhibit nitric oxide-induced neurotoxicity. Int Immunopharmacol 2(11):1551-1556
121. Ahlemeyer B, Mowes A, Krieglstein J (1999) Inhibition of serum deprivation-and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Eur J Pharmacol 367(2-3):423-430
122. Schindowski K, Leutner S, Kressmann S, Eckert A, Muller WE (2001) Age-related increase of oxidative stress-induced apoptosis in mice prevention by Ginkgo biloba extract (EGb761). J Neural Transm 108(8-9):969-978
123. Tian YM, Tian HJ, Zhang GY, Dai YR (2003) Effects of Ginkgo biloba extract (EGb 761) on hydroxyl radical-induced thymocyte apoptosis and on age-related thymic atrophy and peripheral immune dysfunctions in mice. Mech Ageing Dev 124(8-9):977-983
124. Kim KS, Rhee KH, Yoon JH, Lee JG, Lee JH, Yoo JB (2005) Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol 41(4):383-389. doi:10.1016/j.oraloncology.2004.09.013
125. Chan WH (2005) Ginkgolides induce apoptosis and decrease cell numbers in mouse blastocysts. Biochem Biophys Res Commun 338(2):1263-1267. doi:10.1016/j.bbrc.2005.10.085
126. Hu YY, Huang M, Dong XQ, Xu QP, Yu WH, Zhang ZY (2011) Ginkgolide B reduces neuronal cell apoptosis in the hemorrhagic rat brain: possible involvement of Toll-like receptor 4/nuclear factor-kappa B pathway. J Ethnopharmacol 137(3):1462-1468. doi:10.1016/j.jep. 2011.08.034
127. Bastianetto S, Ramassamy C, Dore S, Christen Y, Poirier J, Quirion R (2000) The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci 12(6):1882-1890
128. Yao Z, Drieu K, Papadopoulos V (2001) The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligands. Brain Res 889(1-2):181-190
129. Colciaghi F, Borroni B, Zimmermann M, Bellone C, Longhi A, Padovani A, Cattabeni F, Christen Y, Di Luca M (2004) Amyloid precursor protein metabolism is regulated toward alpha-secretase pathway by Ginkgo biloba extracts. Neurobiol Dis 16(2):454-460. doi:10.1016/j.nbd.2004.03.011
130. Yao ZX, Han Z, Drieu K, Papadopoulos V (2004) Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels. J Nutr Biochem 15(12):749-756. doi:10.1016/j.jnutbio.2004.06.008
131. Lee TF, Chen CF, Wang LC (2004) Effect of ginkgolides on beta-amyloid-suppressed acetylocholine release from rat hippocampal slices. Phytother Res 18(7):556-560. doi:10.1002/ptr.1493
132. Stackman RW, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn JF (2003) Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer’s disease by chronic Ginkgo biloba treatment. Exp Neurol 184(1):510-520
133. Luo Y, Smith JV, Paramasivam V, Burdick A, Curry KJ, Buford JP, Khan I, Netzer WJ, Xu H, Butko P (2002) Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA 99(19):12197-12202. doi:10.1073/pnas.182425199
134. Bate C, Salmona M, Williams A (2004) Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42. J Neuroinflammation 1(1):4. doi:10.1186/1742-2094-1-4
135. Bate C, Tayebi M, Williams A (2008) Ginkgolides protect against amyloid-beta1-42-mediated synapse damage in vitro. Mol Neurodegener 3:1. doi:10.1186/1750-1326-3-1
136. Wu Y, Wu Z, Butko P, Christen Y, Lambert MP, Klein WL, Link CD, Luo Y (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans. J Neurosci 26(50):13102-13113. doi:10.1523/JNEUROSCI.3448-06.2006
137. Watanabe CM, Wolffram S, Ader P, Rimbach G, Packer L, Maguire JJ, Schultz PG, Gohil K (2001) The in vivo neuromodulatory effects of the herbal medicine Ginkgo biloba. Proc Natl Acad Sci USA 98(12):6577-6580. doi:10.1073/pnas.111126298
138. Tchantchou F, Xu Y, Wu Y, Christen Y, Luo Y (2007) EGb 761 enhances adult hippocampal neurogenesis and phosphorylation of CREB in transgenic mouse model of Alzheimer’s disease. FASEB J 21(10):2400-2408. doi:10.1096/fj.06-7649com
139. Augustin S, Rimbach G, Augustin K, Schliebs R, Wolffram S, Cermak R (2009) Effect of a short-and long-term treatment with Ginkgo biloba extract on amyloid precursor protein levels in a transgenic mouse model relevant to Alzheimer’s disease. Arch Biochem Biophys 481(2):177-182. doi:10.1016/j.abb.2008.10.032
140. Longpre F, Garneau P, Christen Y, Ramassamy C (2006) Protection by EGb 761 against beta-amyloid-induced neurotoxicity: involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation. Free Radic Biol Med 41(12):1781-1794. doi:10.1016/j.freeradbiomed.2006.08.015
141. Shi C, Zhao L, Zhu B, Li Q, Yew DT, Yao Z, Xu J (2009) Protective effects of Ginkgo biloba extract (EGb761) and its constituents quercetin and ginkgolide B against beta-amyloid peptide-induced toxicity in SH-SY5Y cells. Chem Biol Interact 181(1):115-123. doi:10.1016/j.cbi.2009.05.010
142. Yan FL, Zheng Y, Zhao FD (2008) Effects of ginkgo biloba extract EGb761 on expression of RAGE and LRP-1 in cerebral microvascular endothelial cells under chronic hypoxia and hypoglycemia. Acta Neuropathol 116(5):529-535. doi:10.1007/s00401-008-0435-6
143. Vitolo O, Gong B, Cao Z, Ishii H, Jaracz S, Nakanishi K, Arancio O, Dzyuba SV, Lefort R, Shelanski M (2009) Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide. J Neurobiol Aging 30(2):257-265. doi:10.1016/j.neurobiolaging.2007.05.025
144. Rhein V, Giese M, Baysang G, Meier F, Rao S, Schulz KL, Hamburger M, Eckert A (2010) Ginkgo biloba extract ameliorates oxidative phosphorylation performance and rescues abeta-induced failure. PLoS One 5(8):e12359. doi:10.1371/journal.pone.0012359
145. Xiao Q, Wang C, Li J, Hou Q, Ma J, Wang W, Wang Z (2010) Ginkgolide B protects hippocampal neurons from apoptosis induced by beta-amyloid 25-35 partly viaup-regulation of brain-derived neurotrophic factor. Eur J Pharmacol 647(1-3):48-54. doi:10.1016/j.ejphar.2010.08.002
146. Li S, Luo J, Wang X, Guan BC, Sun CK (2011) Effects of Ginkgo biloba extracts on NMDA-activated currents in acutely isolated hippocampal neurons of the rat. Phytother Res 25(1):137-141. doi:10.1002/ptr.3235
147. Kanowski S, Herrmann WM, Stephan K, Wierich W, Horr R (1996) Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29(2):47-56. doi:10.1055/s-2007-979544
148. Haase J, Halama P, Horr R (1996) Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type. Z Gerontol Geriatr 29(4):302-309
149. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. J Am Med Assoc 278(16):1327-1332
150. Oken BS, Storzbach DM, Kaye JA (1998) The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55(11):1409-1415
151. Le Bars PL, Kieser M, Itil KZ (2000) A 26-week analysis of a double-blind, placebo-controlled trial of the Ginkgo biloba extract EGb 761 in dementia. Dement Geriatr Cogn Disord 11(4):230-237
152. Le Bars PL, Velasco FM, Ferguson JM, Dessain EC, Kieser M, Hoerr R (2002) Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761 in Alzheimer’s disease. Neuropsychobiology 45(1):19-26
153. Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R (2002) Ginkgo for memory enhancement: a randomized controlled trial. JAMA 288(7):835-840
154. Napryeyenko O, Sonnik G, Tartakovsky I (2009) Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. J Neurol Sci 283(1-2):224-229. doi:10.1016/j.jns.2009.02.353
155. Yancheva S, Ihl R, Nikolova G, Panayotov P, Schlaefke S, Hoerr R (2009) Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer’s disease with neuropsychiatric features: a randomised, double-blind, exploratory trial. Aging Ment Health 13(2):183-190. doi:10.1080/13607860902749057
156. Kasper S, Schubert H (2009) Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability. Fortschr Neurol Psychiatr 77(9):494-506. doi:10.1055/s-0028-1109504
157. Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN (2010) Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatr 10:14. doi:10.1186/1471-2318-10-14
158. Ihl R, Bachinskaya N, Korczyn AD, Vakhapova V, Tribanek M, Hoerr R, Napryeyenko O (2010) Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. Int J Geriatr Psychiatry. doi:10.1002/gps.2662
159. Herrschaft H, Nacu A, Likhachev S, Sholomov I, Hoerr R, Schlaefke S (2012) Ginkgo biloba extract EGb 761((R)) in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg. J Psychiatr Res 46(6):716-723. doi:10.1016/j.jpsychires.2012.03.003
160. Ramassamy C, Clostre F, Christen Y, Costentin J (1990) Prevention by a Ginkgo biloba extract (GBE 761) of the dopaminergic neurotoxicity of MPTP. J Pharm Pharmacol 42(11):785-789
161. White HL, Scates PW, Cooper BR (1996) Extracts of Ginkgo biloba leaves inhibit monoamine oxidase. Life Sci 58(16):1315-1321
162. Yang SF, Wu Q, Sun AS, Huang XN, Shi JS (2001) Protective effect and mechanism of Ginkgo biloba leaf extracts for Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Pharmacol Sin 22(12):1089-1093
163. Cao F, Sun S, Tong ET (2003) Experimental study on inhibition of neuronal toxical effect of levodopa by Ginkgo biloba extract on Parkinson disease in rats. J Huazhong Univ Sci Technolog Med Sci 23(2):151-153
164. Kim MS, Lee JI, Lee WY, Kim SE (2004) Neuroprotective effect of Ginkgo biloba L. extract in a rat model of Parkinson’s disease. Phytother Res 18(8):663-666. doi:10.1002/ptr.1486
165. Rodriguez de Turco EB, Droy-Lefaix MT, Bazan NG (1993) EGb 761 inhibits stress-induced polydipsia in rats. Physiol Behav 53(5):1001-1002
166. Rapin JR, Lamproglou I, Drieu K, DeFeudis FV (1994) Demonstration of the “anti-stress” activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task. Gen Pharmacol 25(5):1009-1016
167. Marcilhac A, Dakine N, Bourhim N, Guillaume V, Grino M, Drieu K, Oliver C (1998) Effect of chronic administration of Ginkgo biloba extract or Ginkgolide on the hypothalamic-pituitary-adrenal axis in the rat. Life Sci 62(25):2329-2340
168. Hasenohrl RU, Nichau CH, Frisch CH, De Souza Silva MA, Huston JP, Mattern CM, Hacker R (1996) Anxiolytic-like effect of combined extracts of Zingiber officinale and Ginkgo biloba in the elevated plus-maze. Pharmacol Biochem Behav 53(2):271-275
169. Hasenohrl RU, Topic B, Frisch C, Hacker R, Mattern CM, Huston JP (1998) Dissociation between anxiolytic and hypomnestic effects for combined extracts of Zingiber officinale and Ginkgo biloba, as opposed to diazepam. Pharmacol Biochem Behav 59(2):527-535
170. Satyan KS, Jaiswal AK, Ghosal S, Bhattacharya SK (1998) Anxiolytic activity of ginkgolic acid conjugates from Indian Ginkgo biloba. Psychopharmacology (Berl) 136(2):148-152
171. Ward CP, Redd K, Williams BM, Caler JR, Luo Y, McCoy JG (2002) Ginkgo biloba extract: cognitive enhancer or antistress buffer. Pharmacol Biochem Behav 72(4):913-922
172. Kuribara H, Weintraub ST, Yoshihama T, Maruyama Y (2003) An anxiolytic-like effect of Ginkgo biloba extract and its constituent, ginkgolide-A, in mice. J Nat Prod 66(10):1333-1337. doi:10.1021/np030122f
173. Walesiuk A, Trofimiuk E, Braszko JJ (2006) Ginkgo biloba normalizes stress-and corticosterone-induced impairment of recall in rats. Pharmacol Res 53(2):123-128. doi:10.1016/j. phrs.2005.09.007
174. Eckmann F, Schlag H (1982) Controlled double-blind study for the determination of the effect of Tebonin forte in patients with cerebrovascular insufficiency. Fortschr Med 100(31-32):1474-1478
175. Hemmeter U, Annen B, Bischof R, Bruderlin U, Hatzinger M, Rose U, Holsboer-Trachsler E (2001) Polysomnographic effects of adjuvant Ginkgo biloba therapy in patients with major depression medicated with trimipramine. Pharmacopsychiatry 34(2):50-59. doi:10.1055/s-2001-15182
176. Jezova D, Duncko R, Lassanova M, Kriska M, Moncek F (2002) Reduction of rise in blood pressure and cortisol release during stress by Ginkgo biloba extract (EGb 761) in healthy volunteers. J Physiol Pharmacol 53(3):337-348
177. Woelk H, Arnoldt KH, Kieser M, Hoerr R (2007) Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. J Psychiatr Res 41(6):472-480. doi:10.1016/j.jpsychires.2006.05.004
178. Armstead WM, Pourcyrous M, Mirro R, Leffler CW, Busija DW (1988) Platelet activating factor: a potent constrictor of cerebral arterioles in newborn pigs. Circ Res 62(1):1-7
179. Akisu M, Kultursay N, Coker I, Huseyinov A (1998) Platelet-activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate 74(6):439-444
180. Otani M, Chatterjee SS, Gabard B, Kreutzberg GW (1986) Effect of an extract of Ginkgo biloba on triethyltin-induced cerebral edema. Acta Neuropathol 69(1-2):54-65
181. Spinnewyn B, Blavet N, Clostre F (1986) Effects of Ginkgo biloba extract on a cerebral ischemia model in gerbils. Presse Med 15(31):1511-1515
182. Lin CC, Cheng WL, Hsu SH, Chang CM (2003) The effects of Ginkgo biloba extracts on the memory and motor functions of rats with chronic cerebral insufficiency. Neuropsychobiology 47(1):47-51. doi:10.1159/000068875
183. Pierre S, Jamme I, Droy-Lefaix MT, Nouvelot A, Maixent JM (1999) Ginkgo biloba extract (EGb 761) protects Na, K-ATPase activity during cerebral ischemia in mice. Neuroreport 10(1):47-51
184. Calapai G, Crupi A, Firenzuoli F, Marciano MC, Squadrito F, Inferrera G, Parisi A, Rizzo A, Crisafulli C, Fiore A, Caputi AP (2000) Neuroprotective effects of Ginkgo biloba extract in brain ischemia are mediated by inhibition of nitric oxide synthesis. Life Sci 67(22):2673-2683
185. Chandrasekaran K, Mehrabian Z, Spinnewyn B, Drieu K, Fiskum G (2001) Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res 922(2):282-292
186. Lee EJ, Chen HY, Wu TS, Chen TY, Ayoub IA, Maynard KI (2002) Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats. J Neurosci Res 68(5):636-645. doi:10.1002/jnr.10251
187. Koh PO (2010) Gingko biloba extract (EGb 761) prevents cerebral ischemia-induced p70S6 kinase and S6 phosphorylation. Am J Chin Med 38(4):727-734
188. Huang M, Qian Y, Guan T, Huang L, Tang X, Li Y (2012) Different neuroprotective responses of Ginkgolide B and bilobalide, the two Ginkgo components, in ischemic rats with hyperglycemia. Eur J Pharmacol 677(1-3):71-76. doi:10.1016/j.ejphar.2011. 12.011
189. Yang ZZ, Li J, Li SX, Feng W, Wang H (2011) Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats. J Ethnopharmacol 136(1):117-122. doi:10.1016/j.jep. 2011.04.027
190. Ma S, Yin H, Chen L, Liu H, Zhao M, Zhang X (2012) Neuroprotective effect of ginkgolide K against acute ischemic stroke on middle cerebral ischemia occlusion in rats. J Nat Med 66(1):25-31. doi:10.1007/s11418-011-0545-7
191. Mdzinarishvili A, Sumbria R, Lang D, Klein J (2012) Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain. J Pharm Pharm Sci 15(1):94-102
192. Spinnewyn B, Blavet N, Clostre F, Bazan N, Braquet P (1987) Involvement of plateletactivating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils. Prostaglandins 34(3):337-349
193. Panetta T, Marcheselli VL, Braquet P, Spinnewyn B, Bazan NG (1987) Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: inhibition of ischemia-reperfusion induced cerebral injury. Biochem Biophys Res Commun 149(2):580-587
194. Birkle DL, Kurian P, Braquet P, Bazan NG (1988) Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. J Neurochem 51(6):1900-1905
195. Liu XH, Eun BL, Silverstein FS, Barks JD (1996) The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res 40(6):797-803
196. Li S, Meng Q, Zhang L (1999) Experimental therapy of a platelet-activating factor antagonist (ginkgolide B) on photochemically induced thrombotic cerebral ischaemia in tree shrews. Clin Exp Pharmacol Physiol 26(10):824-825
197. Yang ZZ, Li J, Li SX, Feng W, Wang H (2011) Effect of ginkgolide B on striatal extracellular amino acids in middle cerebral artery occluded rats. J Ethnopharmacol 136(1):117-122. doi:10.1016/j.jep. 2011.04.027
198. Vorberg G (1985) Ginkgo biloba extract (GBE*): A long-term study of chronic cerebral insufficiency in geriatric patients. Clin Trials J 22(2):149-157
199. Taillandier J, Ammar A, Rabourdin JP, Ribeyre JP, Pichon J, Niddam S, Pierart H (1986) Treatment of cerebral aging disorders with Ginkgo biloba extract. A longitudinal multicenter double-blind drug vs. placebo study. Presse Med 15(31):1583-1587
200. Kleijnen J, Knipschild P (1992) Ginkgo biloba for cerebral insufficiency. Br J Clin Pharmacol 34(4):352-358
201. Szabo ME, Droy-Lefaix MT, Doly M, Braquet P (1991) Free radical-mediated effects in reperfusion injury: a histologic study with superoxide dismutase and EGB 761 in rat retina. Ophthalmic Res 23(4):225-234
202. Szabo ME, Droy-Lefaix MT, Doly M, Braquet P (1993) Modification of ischemia/reperfu-sion-induced ion shifts (Na+, K+, Ca2+ and Mg2+) by free radical scavengers in the rat retina. Ophthalmic Res 25(1):1-9
203. Baudouin C, Ettaiche M, Fredj-Reygrobellet D, Droy-Lefaix MT, Gastaud P, Lapalus P (1992) Effects of Ginkgo biloba extracts in a model of tractional retinal detachment. Lens Eye Toxic Res 9(3-4):513-519
204. Doly M, Bonhomme B, Braquet P, Chabrier PE, Meyniel G (1987) Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. Immunopharmacology 13(3):189-194
205. Droy-Lefaix MT, Szabo ME, Doly M (1993) Ischaemia and reperfusion-induced injury in rat retina obtained from normotensive and spontaneously hypertensive rats: effects of free radical scavengers. Int J Tissue React 15(2):85-91
206. Pritz-Hohmeier S, Chao TI, Krenzlin J, Reichenbach A (1994) Effect of in vivo application of the Ginkgo biloba extract EGb 761 (Rokan) on the susceptibility of mammalian retinal cells to proteolytic enzymes. Ophthalmic Res 26(2):80-86
207. McCarty MF (1998) Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to the pathogenesis of diabetic retinopathy/neuropathy-preventive potential of antioxidants, essential fatty acids, chromium, ginkgolides, and pentoxifylline. Med Hypotheses 50(5):435-449
208. Hirooka K, Tokuda M, Miyamoto O, Itano T, Baba T, Shiraga F (2004) The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma. Curr Eye Res 28(3):153-157. doi:10.1076/ceyr.28.3.153.26246
209. Xie Z, Wu X, Gong Y, Song Y, Qiu Q, Li C (2007) Intraperitoneal injection of Ginkgo biloba extract enhances antioxidation ability of retina and protects photoreceptors after light-induced retinal damage in rats. Curr Eye Res 32(5):471-479. doi:10.1080/02713680701257621
210. Ma K, Xu L, Zhan H, Zhang S, Pu M, Jonas JB (2009) Dosage dependence of the effect of Ginkgo biloba on the rat retinal ganglion cell survival after optic nerve crush. Eye (Lond) 23(7):1598-1604. doi:10.1038/eye.2008.286
211. Ma K, Xu L, Zhang H, Zhang S, Pu M, Jonas JB (2010) The effect of Ginkgo biloba on the rat retinal ganglion cell survival in the optic nerve crush model. Acta Ophthalmol 88(5):553-557. doi:10.1111/j.1755-3768.2008.01486.x
212. Koh PO (2011) Ginkgo biloba extract (EGb 761) attenuates the focal cerebral ischemic injury-induced decrease in astrocytic phosphoprotein PEA-15 levels. Am J Chin Med 39(5):971-979. doi:10.1142/S0192415X11009342
213. Lebuisson DA, Leroy L, Rigal G (1986) Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double-blind drug vs. placebo study. Presse Med 15(31):1556-1558
214. Lanthony P, Cosson JP (1988) The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study. J Fr Ophtalmol 11(10):671-674
215. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R (1999) Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther 15(3):233-240
216. Fies P, Dienel A (2002) Ginkgo extract in impaired vision-treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration. Wien Med Wochenschr 152(15-16):423-426
217. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E (2003) Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology 110(2):359-362. doi:10.1016/S0161-6420(02)01745-1; discussion 362-354
218. Wimpissinger B, Berisha F, Garhoefer G, Polak K, Schmetterer L (2007) Influence of Ginkgo biloba on ocular blood flow. Acta Ophthalmol Scand 85(4):445-449. doi:10.1111/j.1600-0420.2007.00887.x
219. Dorairaj S, Ritch R, Liebmann JM (2007) Visual improvement in a patient taking Ginkgo biloba extract: a case study. Explore (NY) 3(4):391-395. doi:10.1016/j.explore.2007.04.011
220. Denise P, Bustany P (1989) The effect of extract of Ginkgo biloba (EGb 761)® on central compensation of a total unilateral peripheral vestibular deficit in the rat. In: Lacour M, Toupet M, Denise P, Christen Y (eds) Vestibular compensation: facts, theories and clinical perspectives. Elsevier, Paris, pp 201-208
221. Ez-Zaher L, Lacour M (1989) Effects of post-operative treatment with an extract of Ginkgo biloba (EGb-761) on vestibular compensation in the cat. In: Lacour M, Toupet M, Denise P, Christen Y (eds) Vestibular compensation: facts, theories and clinical perspectives. Elsevier, Paris, pp 209-223
222. Lacour M, Ez-Zaher L, Raymond J (1991) Plasticity mechanisms in vestibular compensation in the cat are improved by an extract of Ginkgo biloba (EGb 761). Pharmacol Biochem Behav 40(2):367-379
223. Yabe T, Chat M, Malherbe E, Vidal PP (1992) Effects of Ginkgo biloba extract (EGb 761) on the guinea pig vestibular system. Pharmacol Biochem Behav 42(4):595-604
224. Tighilet B, Lacour M (1995) Pharmacological activity of the Ginkgo biloba extract (EGb 761) on equilibrium function recovery in the unilateral vestibular neurectomized cat. J Vestib Res 5(3):187-200
225. Maclennan K, Smith PF, Darlington CL (1995) Ginkgolide B accelerates vestibular compensation of spontaneous ocular nystagmus in guinea pig following unilateral labyrinthectomy. Exp Neurol 131(2):273-278
226. Claussen CF, Kirtane MV (1985) Randomisierte Doppelblindstudie zur Wirkung von Extractum Ginkgo biloba bei Schwindel und Gangunsicherheit des alteren Menschen. In: Claussen CF (ed) Presyvertigo, Presbyataxie, Presbytinnitus. Springer, Berlin, pp 103-115
227. Hamann KF (1985) Vestibular vertigo treated by physical therapy in association with Ginkgo biloba extract [Physikalische Therapie des vestibularen Schwindels in Verbindung mit Ginkgo biloba Extrakt]. Therapiewoche 35(40):4586-4590
228. Haguenauer JP, Cantenot F, Koskas H, Pierart H (1986) Traitement des troubles de l’equlibre par l’extrait de Ginkgo biloba [Treatment of equilibrium disorders with Ginkgo biloba extract. A multicenter double-blind drug vs. placebo study]. Presse Med 15(31):1569-1572
229. Hamann KF (2002) Fahrtuchtigkeit bei vestibularen Lasionen. HNO 50(12):1086-1088. doi:10.1007/s00106-002-0771-0
230. Orendorz-Fraczkowska K, Pospiech L, Gawron W (2002) Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo bilobaextract (Egb 761). Otolaryngol Pol 56(1):83-88
231. Hamann KF (2007) Special ginkgo extract in cases of vertigo: a systematic review of randomised, double-blind, placebo controlled clinical examinations. HNO 55(4):258-263. doi:10.1007/s00106-006-1440-5
232. Ching-Hsiang L, Chiao-Wen H, Nan-Fu C, Wen-Sheng L, Ya-Fen H, Wen-Tung W (2012) In vivo effects of Ginkgo biloba extract on interleukin-6 cytokine levels in patients with neurological disorders. Indian J Pharmacol 44(1):118-121. doi:10.4103/0253-7613.91881
233. Brochet B, Orgogozo JM, Guinot P, Dartigues JF, Henry P, Loiseau P (1992) Pilot study of Ginkgolide B, a PAF-acether specific inhibitor in the treatment of acute outbreaks of multiple sclerosis. Rev Neurol (Paris) 148(4):299-301
234. Brochet B, Guinot P, Orgogozo JM, Confavreux C, Rumbach L, Lavergne V (1995) Double blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis. J Neurol Neurosurg Psychiatry 58(3):360-362
235. Buchanan DC, Kochanek PM, Nemoto EM, Melick JA, Schoettle RJ (1989) Plateletactivating factor receptor blockade decreases early posttraumatic cerebral edema in rats. Ann N Y Acad Sci 559:427-428
236. Faden AI, Tzendzalian PA (1992) Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. Am J Physiol 263(4 Part 2):R909-914
237. D-L W, Liang Y, W-D C, Xie L, G-J W, X-D L (2008) Identification of ginkgolide B metabolites in urine and rat liver cytochrome P450 enzymes responsible for their formation in vitro. Acta Pharmacol Sin 29(3):376-384
238. Drago F, Floriddia ML, Cro M, Giuffrida S (2002) Pharmacokinetics and bioavailability of a Ginkgo biloba extract. J Ocul Pharmacol Ther 18(2):197-202. doi:10.1089/108076802317373941
239. Fourtillan JB, Brisson AM, Girault J, Ingrand I, Decourt JP, Drieu K, Jouenne P, Biber A (1995) Pharmacokinetic properties of bilobalide and ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761). Therapie 50(2):137-144
240. Stromgaard K, Nakanishi K (2004) Chemistry and biology of terpene trilactones from Ginkgo biloba. Angew Chem Int Ed Engl 43(13):1640-1658. doi:10.1002/anie.200300601
241. Pennisi RS (2006) Acute generalised exanthematous pustulosis induced by the herbal remedy Ginkgo biloba. Med J Aust 184(11):583-584
242. Davydov L, Stirling AL (2001) Stevens-Johnson syndrome with Ginkgo Biloba. J Herb Pharmacother 1(3):65-69. doi:10.1080/J157v01n03_06
243. Haemorrhage due to Ginkgo biloba? (2008). Prescrire Int 17 (93):19